Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John L. Slunecka
Observed names:
John Slunecka,
John l. Slunecka,
Slunecka, John
Institution:
University of South Dakota
Observed institutions:
University of South Dakota,
Avera McKennan Hospital & University Health Center,
Avera Institute for Human Genetics
ORCID:
0000-0001-6462-1146
Observed ORCID:
0000-0001-6462-1146
OpenAlex ID:
A5087692453
Implementation and implications for polygenic risk scores in healthcare
2021
·
John L. Slunecka
, Matthijs D. van der Zee
, et al.
·
Human Genomics
·
134
PDF
UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells
2018
·
Sanam Sane
, Andre Hafner
, et al.
·
Molecular Oncology
·
36
PDF
A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
2023
·
David Starks
, Luis Rojas‐Espaillat
, et al.
·
Cancer Medicine
·
6
Liver-Specific Nanoparticle-Mediated Delivery and MMP-Triggered Release of Veratridine to Effectively Target Metastatic Colorectal Cancer
2025
·
Mahadi Hasan
, Morgan Eikanger
, et al.
·
Cancers
·
3
PDF
Veratridine, a plant-derived alkaloid, suppresses the hyperactive Rictor-mTORC2 pathway: a new targeted therapy for primary and metastatic colorectal cancer
2024
·
Morgan M. Eikanger
, Sanam Sane
, et al.
·
Research Square
·
3
PDF
Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation
2024
·
Jeffrey J. Beck
, John L. Slunecka
, et al.
·
Cancers
·
3
PDF
Show more works
View as search
Works count:
7
Citation count:
185
H-index:
3
I10-index:
2
Year
Topic
Type